Table 3 Treatment of AIS patients in PHOTAR and PUFH
PHOTAR (n = 236) | PUFH (n = 1021) | P-Value | |
|---|---|---|---|
Thrombolysis, n (%) | 1 (0.4) | 53 (5.2) | 0.001 |
Antihypertensive drugs, n (%) | 133 (56.4) | 679 (66.7) | 0.003 |
Antidiabetic drugs, n (%) | 24 (10.2) | 383 (37.7) | < 0.001 |
Antihyperlipidemic drugs, n (%) | 173 (73.3) | 914 (89.7) | < 0.001 |
ICP-lowering drugs, n (%) | 51 (21.6) | 48 (4.7) | < 0.001 |
Antiplatelet drugs, n (%) | 197 (83.5) | 941 (92.4) | < 0.001 |
Anticoagulants, n (%) | 19 (8.1) | 231 (22.7) | < 0.001 |